Tenet Healthcare 15% Shareholder Glenview Capital Issues Letter of Support for Spin-Off of Conifer by Mid 2022
On February 10, 2021, Glenview Capital Management, Tenet Healthcare's largest shareholder, publicly supported the spin-off of Tenet's Conifer subsidiary in a tax-free transaction set for mid-2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
On February 10, 2021, Glenview Capital Management, Tenet Healthcare's largest shareholder, publicly supported the spin-off of Tenet's Conifer subsidiary in a tax-free transaction set for mid-2022. Glenview's CEO, Larry Robbins, praised Tenet's focus on patient and worker safety during the Covid-19 pandemic and emphasized that the spin-off would enhance Conifer's growth and shareholder value. With $3.5 billion in assets under management, Glenview aims to aid Tenet in evolving towards a higher ambulatory mix and promoting strong cash generation.
Positive
- Support from largest shareholder for spin-off, indicating confidence in strategic direction.
- Potential for enhanced growth and shareholder value from independent Conifer subsidiary.
Negative
- None.
Details
News Market Reaction – THC
The recorded move for THC in the trading session of this news was -3.78%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Feb. 10, 2021 /PRNewswire/ -- Glenview Capital Management ("Glenview"), the largest shareholder of Tenet Healthcare Corporation ("Tenet" or the "Company") (NYSE:THC), today announced that it confirms its support of the Board's decision to spin-off the Company's Conifer subsidiary to shareholders in a tax-free transaction in mid-2022.
"We applaud the people of Tenet's resilience and focus on the front lines of the battle against Covid-19, and we support management's focus on worker and patient safety, operating efficiency and maximizing the number of patients who may be safely cared for throughout the pandemic," said Larry Robbins, Glenview CEO. "We believe Conifer's current and future customers will be best served through a continued growth of Conifer's capabilities, and we believe that all shareholders will benefit from Tenet's logical approach to launch Conifer as an independent Company by mid-2022 while continuing to evolve the Tenet portfolio to higher ambulatory mix, accelerating growth and strong cash generation."
About Glenview Capital Management
Glenview Capital is an investment management firm with
Media Contact:
Prosek Partners (on behalf of Glenview)
Mike Geller
Partner
mgeller@prosek.com
View original content:http://www.prnewswire.com/news-releases/tenet-healthcare-15-shareholder-glenview-capital-issues-letter-of-support-for-spin-off-of-conifer-by-mid-2022-301225935.html
SOURCE Glenview Capital Management
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.